laporan praktikum farmakoterapi ii p.1 ggk

Upload: lailakasturi

Post on 01-Mar-2018

233 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    1/21

    LAPORAN PRAKTIKUM FARMAKOTERAPI II

    PENYAKIT CRF DENGAN ASCITES

    Disusun oleh:

    1. WILDATUS SOLIA !G1F"1#""$%

    #. SYNTIA APDA&UNA PUTRI !G1F"1#"1#%'. NO(IANTI DIAN LESTARI !G1F"1#"#"%$. ISANTI DWI RAAYU !G1F"1#"#)%*. DE(A EFA AFILA !G1F"1#"'+%+. GINAN&AR WAYU R. !G1F"1#"$$%,. DORIS DE--Y C. S. !G1F"1#"*#%). ANITA KURNIA !G1F"1#"+"%. WAYU NUNGGAL P. !G1F"1#",#%1". AFIA RO-ITO !G1F"1#")"%11. PUTRI MARGARETA !G1F"1#"))%

    Dosen Pe/0i/0in : Tunul A2i P.3 M.S4.3 A56T7n7l Dis8usi Dosen : Sel7s73 , A59il #"1*

    N7/7 Asis6en : K78 Ti7T7n7l Dis8usi Kelo/5o8 : '1 M79e6 #"1*

    LA-ORATORIUM FARMASI KLINIK&URUSAN FARMASI

    FAKULTAS ILMUILMU KESEATANUNI(ERSITAS &ENDERAL SOEDIRMAN

    #"1*CRF DENGAN ASCITES

    A. KASUS

    1) I2en6i67s P7sien

    N7/7 P7sien Ds9 U/u9;TTL *' 67hun

    No. Re87/ Me2i8 ,#))#+ --

    Al7/76 Pelu67n T-

    S676us &7/in7n &e/8es/7s &enis Kel7/in L78il78i

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    2/21

    #% Ri

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    3/21

    7

    $% D767 L70o976o9iu/

    Pe/e9i8s77n S76u7n T7n7l

    1,;1 1);1 1;1 #";1 #1;1 ##;1 #';1

    K //ol;L *3$

    C7 /;2L ,3+

    0 ;2L 3# )3* 113

    Leu8osi6 ;uL 1*+," 1'$$" 1#"" '$"""

    CT #* #$ '$

    E9i69osi6 1"+;uL '3$ '3# $3#

    MC( >l ,$31 ,$3'

    MC 5 #+3) #+3+

    RDW 1$3, 1$3

    Eosino>il 13' 1

    -767n "3"" "3"" "3"

    Se/en ))3$ )*3' "3""

    Li/>osi6 ))3$ )*3' ),3#

    Monosi6 13 1"3#

    To6. P9o6ein ;2L )3,

    Al0u/in ;2L '3")

    Glo0ulin ;2L *3+#

    SGOT u;L *1

    U9eu/2797h

    /;2L 1,3, 1)#31 1*)3$

    SC9 /;2L 1'3#$ 113'# 1"3$#

    *% Pe/e9i8s77n PenunB7n

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    4/21

    N7/7Pe/e9i8s77n:

    7sil

    EKG !?%Puns As4i6es !?%T7n7l:

    1);"1;#"1'

    +% Te975i

    O076 Dosis F9e T7n7l

    1,;1 1);1 1;1 #";1 #1;1 ##;1 #';1

    O# $ l5/

    In> D* 1" 65/ 1" 65/

    InB A/5i4illin 1 9

    InB L7si #A i

    InB R7n6in 1A i # /l*" /

    -i4n76 # >l7sh29i5 27l7/ D**"" 44

    In1).#$.!# seh79i%*" /

    A/lo2i5in 1" /670 1)#$B7/

    !1 seh79i%

    D

    P9o T97ns>usiPRC

    # 197/

    Ce>69i7on i

    N7/7Pe/e9i8s77n:

    7sil

    EKG !?%

    Puns As4i6es !?%T7n7l:

    1);"1;#"1'

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    5/21

    ,% Te975i S776 KRS

    N7/7 O076 Dosis F9e8uensi &u/l7h

    -. DASAR TEORI1. PATOFISIOLOGI

    Patofisiologi Gagal Ginjal Kronik

    G77l inB7l 89oni8 /e9u5787n 5enu9un7n l7Bu >il697si 2i

    lo/e9ulus3 h7l i6u 2ise07087n 879en7 6e927576 576oen 767u 0is7 6e9B72i

    879en7 2i70e6es /elli6us3 sel7in i6u 0is7 Bu7 6e9B72i 879en7796e9ios4le9osis. &i87 77l inB7l 2ise07087n oleh 576oen3 /787 576oen

    6e9se0u6 787n /e9us78 lo/e9ulus sehin7 l7Bu >il697sin=7 /enB72i

    6u9un. &i87 77l inB7l 2ise07087n oleh 2i70e6es /elli6us Bu7 787n

    0e927/578 s7/73 =7i6u 787n /e9us78 lo/e9ulus 27n l7Bu >il697sin=7

    /enu9un3 h7l ini 2ise07087n 879en7 87279 ul7 2797h 5727 57sien

    2i70e6es le0ih 6ini 279i5727 57sien =7n 6i278 /en2e9i67 2i70e6es3

    se/en6797 inB7l /e/5un=7i 0767s7n 6e9sen2i9i un6u8 /en=79in ul72797h. Pen=e070 l7in =7n /en=e07087n 77l inB7l 89oni8 =7i6u

    796e9ios4le9osis. A96e9ios4le9osis /e9u5787n 8e9us787n 5727 796e9i3

    sehin7 7li97n 2797h 8e lo/e9ulus /enB72i 6u9un. 7l i6u /en=e07087n

    5enu97n7n 5727 27e97h >il697si =7n /en=e07087n 5e9u07h7n 7li97n

    2797h sehin7 7li97n 2797h 2i lo/e9ul79 787n /enin876 27n 6e87n7n 2i

    875ile9 lo/e9ulusn=7 /enin8763 8e6i87 6e87n7n 2i 875ile9 /enin8763

    /787 5e9/e70ili67sn=7 /enB72i 8u97n sehin7 59o6ein59o6ein =7n

    seh79usn=7 6e967h7n 2i lo/e9ulus /enB72i /7su8 8e inB7l. A27n=7

    59o6ein 2i 27l7/ inB7l ini 0e9si>76 ne>9o6o8si8 !se/78in /e9us78 inB7l%3

    sehin7 787n 6e9B72i 59o9esi 8e9us787n inB7l.

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    6/21

    !Di5i9o ,6h e23 #"")%.

    Hubungan Patofisiologi Ascites-CKD-Sirosis Hati

    Ke/un8in7n /e87nis/e 6e9B72in=7 hu0un7n 7n6797 CKD

    As4i6esSi9osis 727l7h P7sien 5727 7unsi un6u8 /enh7sil87n 59o6ein =7n seh79usn=7 727

    5727 2797h. -e98u97nn=7 olu/e si98ul7si ini 6e9B72i 879en7 59o6ein

    5727 2797h 0e98u97n !2797h en4e9%3 sehin7 6u0uh 787n 0e9us7h7

    /el78u87n 8o/5ens7si 0e9u57 5enin8767n sis6e/ RAAS 779 olu/

    6u0uh /enB72i no9/7l. A8i076 8e9B7 inB7l =7n 0e9le0ih7n3 inB7l 787n/en7l7/i 5enu9un7n GFR 27n suli6 un6u8 /ene8s89esi87n u9ine3

    u9eu/3 hi5on769e/i73 2ll.

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    7/21

    (DAPUS).

    #. GUIDELINE TERAPI

    !&NC )3 #"1$%.

    P727 57sien =7n 6e98en7 hi5e96ensi 5e9lu 2il78u87n 5e907i87n

    7=7 hi2u5 se5e96i ol7h 977 6e976u93 /e/5e907i8i 5ol7 /787n =7n

    0e96uBu7n un6u8 /enu9un87n 6e87n7n 2797h =7n /enin876. Den7n

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    8/21

    /e/in7lisi9 un6u8 6e98en7n=7 2i70e6es 27n CKD 5727 5en2e9i67

    i5e96ensi. &i87 57sien /en7l7/i hi5e96ensi s7B7 67n57 727n=7 5en=78i6

    l7in se5e96i 2i70e6es 27n CKD 5727 usi7 8u97n 279i +" 67hun /787

    6e87n7n 2797h se07i8n=7 S-P 1*" // 27n D-P " //. &i87

    5727 57sien 2en7n usi7 le0ih 279i +" 67hun 6e87n7n 2797h se07i8n=7 S-P

    1$" // 27n D-P " // 779 6i278 6e9B72i i5e96ensi. &i87

    57sien /en7l7/i hi5e96ensi 27n 2i70e6es -loo2 59essu9e o7l S-P 1$"

    // 27n D-P " //3 se27n87n 5727 57sien hi5e96ensi 2en7n

    CKD -loo2 59essu9e o7l S-P 1$" // D-P " //. Pe/0e9i7n

    6e975i un6u8 57sien =7n 6e98en7 hi5e96ensi 2i0e9i87n 6e975i 2en7n

    2iu9e6i8 Benis 6hi7Hi2e 27n ACEI 767u AR- 767u CC-3 2en7n 5e/0e9i7no076 se4797 sen2i9isen2i9i 767u 27l7/ 8o/0in7si. Se27n87n 5727 57sien

    =7n /en7l7/i hi5e96ensi 27n 2i70e6es 2i0e9i 2iu9e6i8 Benis 6hi7Hi2e 767u

    CC- s7B7 767u 27l7/ 8o/0in7si. P7sien 2en7n hi5e96ensi 27n CKD 2i0e9i

    6e975i ACEI 767u AR-3 2en7n 5e/0e9i7n o076 se4797 sen2i9isen2i9i 767u

    27l7/ 8o/0in7si 2en7n o076 olon7n l7in. Un6u8 /en2757687n h7sil

    =7n le0ih 07i8 2il78u87n 0e0e9757 s6976ei un6u8 6e975i o076n=7:

    7% M78si/7l87n o076 6e9le0ih 27hulu se0elu/ /en7/07h87n 8e2u7 767u

    0% T7/07h o076 8e2u7 se0elu/ /en4757i 2osis /78si/u/ o076 5e967/7

    767u

    4% Mul7i 2en7n # 8el7s o076 se4797 6e95is7h 767u se077i 8o/0in7si

    2osis 6e675.

    7l 6e9se0u6 0e0e9757 h7l =7n 5e9lu 2i5e9h76i87n /en2757687n h7sil =7n

    le0ih 07i8. Un6u8 /e/5e98u76 5eno0767n 27n 8e576uh7n 7=7 hi2u5.

    Un6u8 s6976ei A 27n -3 /en7/07h 27n 2iu9e6i8 Benis 6hi7Hi2e 767u ACEI

    767u AR- 767u CC- !5enun77n 8el7s o076 =7n se0elu/n=7 6i278

    2i5ilih 27n /enhin279i 5enun77n 70un7n ACEI 27n AR-%. Un6u8

    s6976ei C3 6i697si 2osis o076 7

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    9/21

    8el7s o076 !e3 0lo48e93 7n67onis 7l2os6e9on3 767u o97n l7in% 27n 767u

    /e9uBu8 8e 2o86e9 2en7n 8e7hli7n 27l7/ /7n7Be/en hi5e96ensi. Pe9lun=7

    2il78u87n 69e76/en6 6e9se0u6 2en7n 07i8 27n /e/oni6o9in o076 2en7n

    sesu7i !&NC )3 #"1$%.

    C. PENATALAKSANAAN KASUS DAN PEM-AASAN1. SU-&EKTIF

    N7/7 P7sien : D7so9iAl7/76 : Pelu67n

    No RM : ,#.))#+U/u9 : *' 6hn--;T- :

    S676us &7/in7n : &7/8es/7sMRS : 1,;"'#"1'KRS : #';"'#"1'Ri

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    10/21

    -AK l7n4

    79

    L7n4

    79-A-

    Mu7l ?Pe9u6

    0es79

    !he9ni

    7%

    ?

    !A8h/72i3 #"1$%Ke6e97n7n: TD F786o9 =7n /e/5en79uhi 6e87n7n 2797h =7i6u 6e87n7n 5e/0uluh

    2797h 6e5i3 olu/e 2797h 6o67l3 is8osi67s 2797h 27n 8elen6u97n 2in2in

    796e9i. P797/e6e9 =7n 2iu8u9 727l7h 6e87n7n /78si/7l 5727 2in2in 796e9i

    sel7/7 8on6978si e96i8el 8i9i. N72i P7sien /en7l7/i 678i8792i73 =7i6u 2en=u6 B7n6un 4e576 le0ih 279i

    nil7i no9/7l. -i7s7n=7 6e9B72i 5727 57sien =7n 2e/7/3 >eo89o/osi6o/73

    4ones6i> he796 >7ilu9e3 s=o8 hi5oole/i83 79i6/i7 8o92is3 5e47n2u 8o5i 27n

    9o8o8. RR L7Bu 5e9n7>7s7n /enin876 5727 8e7277n s69ess3 8el7in7n /e670oli83

    5en=78i6 B7n6un 579u. Suhu Suhu 6u0uh 2i5en79uhi oleh i97/7 si9872i7n3 usi73 Benis 8el7/in3

    s69ess3 suhu lin8un7n3 ho9/on 27n ol7h977. Suhu 6u0uh /en4e9/in87n

    8esei/07n7n 7n6797 5e/0en6u87n 27n 5enelu797n 57n7s. Pus76

    5en76u97n suhu 6e927576 2i hi5o67l7/us3 0il7 suhu 6u0uh /ele0ihi suhu

    no9/7l3 /787 5enelu797n 57n7s /enin876 27n se07li8n=7 0il7 suhu 6u0uh

    9en27h !A8h/72i3 #"1$%. Ses78 n7>7s 2ise07087n 879en7 7nu7n i97/7 B7n6un !RR% Le/7s 2ise07087n 879en7 sus7h -A- Mu7l 2ise07087n 879en7 8e7277n u9e/i8 !87279 u9e7 27l7/ 2797h =7n

    /enin876% Sus7h -A- 2ise07087n 879en7 8e8u97n7n 47i97n. Pe9u6 /e/0es79 879en7 sus7h -A- !S7n6os73 #"",%.

    Pe"eriksaan !ilai

    !or"al

    Tanggal Keterangan

    #$%# #&%# #'%# %# #%# %# *%#

    K '3) J * *3$ No9/7l

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    11/21

    //ol;L

    C7 )3) J1"3$

    /;2L

    ,3+ Tu9un !1,;1%

    0 1# J 1+3*;2L

    3# )3* 113 Tu9un!1,31)3#";1%

    Leu8osi6 '#"" J1"""";uL

    1*+," 1'$$" 1#"" '$""" Menin876!1,31)3#"3##%

    CT '* J *" #* #$ '$ Tu9un!1,31)3#";1%

    E9i69osi6 '3) J *3+1"+;uL

    '3$ '3# $3# Tu9un!1,31);1%

    MC( )" J 1"">l

    ,$31 ,$3' Tu9un!1,31);1%

    MC #+ J '$5

    #+3) #+3+ Tu9un!1,31);1%

    RDW 1$3* 1$3, 1$3 Menin876

    !1,3 1);1%

    Eosino>il "* 13' 1 No9/7l

    -767n #+ "3"" "3"" "3" Tu9un3in2i87siin>e8si

    Se/en *"," ))3$ )*3' "3"" N7i83in2i87siin>e8si

    Li/>osi6 #"'* ))3$ )*3' ),3# Tu9un3in2i87siin>e8si

    Monosi6 #) 13 1"3# N7i83in2i87siin>e8si

    To6. P9o6ein +3')3);2L

    )3, No9/7l

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    12/21

    Al0u/in '3)*3$;2L

    '3") Tu9un3hi5o7l0u/in

    Glo0ulin #3+'3+

    ;2L

    *3+# N7i8

    SGOT ', u;L *1 N7i838e9us787nh76i

    U9eu/ 2797h *#*/;2L

    1,3, 1)#31 1*)3$ N7i837si2osis/e670oli8

    SC9 "3*13#

    /;2L

    1'3#$ 113'# 1"3$# N7i83 >unsi

    inB7l/enu9un

    !Ke/en8es RI3 #"11%.

    Ke6e97n7n: CT;e/76o89i6 /enunBu87n 5e9sen67se sel 2797h /e97h 6eh7275 olu/e

    2797h 6o67l. Penu9un7n nil7i 46 /e9u5787n in2i876o9 7ne/i7 !879en7

    0e9077i se070%3 9e78si he/oli6i83 leu8e/i73 si9osis3 8ehil7n7n 07n=78

    2797h 27n hi5e96i9oi2. Penu9un7n 46 se0es79 '" /enunBu887n 57sien/en7l7/i 7ne/i7 se27n hin7 5797h.

    -;e/olo0in 727l7h 8o/5onen =7n 0e9>unsi se077i 7l76 697ns5o967si

    o8sien !O#% 27n 8790on 2io8si27 !CO#%. Penu9un7n 59o6ein 0 no9/7l

    6i5e A13 A#3 F !>e67l% 27n S 0e9hu0un7n 2en7n 7ne/i7 sel s70i6. Bu/l7h

    he/olo0in 8u97n 279i 1# /;2L /enunBu887n 7ne/i7. Nil7i leu8osi6 =7n s7n76 6ini !2i 767s #".""";//'% 27576 2ise07087n

    oleh leu8e/i7. Pen2e9i67 87n8e9 5os6o5e97si !se6el7h /enB7l7ni o5e97si%

    /enunBu887n 5ul7 5enin8767n leu8osi6 e8si. E9i69osi6 /enu9un 879en7 5enu9un7n >unsi inB7l C7;i5o87lse/i7 27576 2i78i07687n oleh hi5e9>os>76e/i73 7l87losis3

    os6eo/7l7si73 5en7n6i7n 87lsiu/ =7n 6i278 /en4u8u5i3 5enun77n

    l78s76i>3 >u9ose/i2e3 27n 5e/0e9i7n 87lsi6onin. Pseu2ohi5o87lse/i7

    8727n8727n 2i6e/u87n 0il7 8onsen697si 7l0u/in 9en27h 879en7 727n=7

    70un7n 87lsiu/ 2en7n 7l0u/in

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    13/21

    Penu9un7n nil7i MC( 6e9lih76 5727 57sien 7ne/i7 8e8u97n7n 0esi3

    7ne/i7 5e9nisios7 27n 67l7se/i73 2ise0u6 Bu7 7ne/i7 /i89osi6i8. Penu9un7n MC /enin2i87si87n 7ne/i7 /i89osi6i8 !Ke/en8es RI3

    #"11%. Penin8767n RDW 27n MC( 6u9un3 2i87i687n 2en7n 8e6en6u7n se077i

    0e9i8u6: Ke8u97n7n H76 0esi3 S70i6 sel6h7l7sse/i7. Li/5osi6 : S7n76 Tu9un3 879en7 s7l7h s76u leu8osi6 =7n 0e95e97n 27l7/

    59oses 8e8e07l7n 27n 5e/0en6u87n 7n6i0o2i3 5enu9un7n li/5osi6 =7n

    s7n76 9en27h 6e9B72i 5727 5en2e9i67 77l inB7l. Monosi6 : /enin876. Penin8767n /onosi6 6e9B72i 879en7 in>e8si i9us3

    5797si6 !/is7l87n 474in%.

    SGOT : Menin876. Penin8767n SGOT 6e9B72i 879en7 727n=7 9727n o6o6B7n6un3 si9osis he576i6is3 27n in>798 579u.

    S49 : S7n76 /eni876. Penin8767n S49 27l7/ 2797h 6e9B72i e8s89esi

    /el7lui s7lu97n 4e9n7. -767n : Menin876 879en7 in>e8si 0786e9i Se/en : Menin876 879en7 in>e8si 0786e9i 27n i9us. U9eu/ 2797h : Menin876. K7279 u9eu/ 2797h 4e576 /enini 279i 5727

    49e76inin 0il7 >unsi inB7l 9us78. Al0u/in : Tu9un

    Al0u/in 879en7 2i0u76 oleh h76i3 /787 5enu9un7n 7l0u/in se9u/27576 /en=e07087n 279i 5en=78i6 h76i 89oni83 inB7l3 s7lu97n 4e9n7

    89oni8327n in>e8si 6e96en6u. Penu9un7n 7l0u/in se9u/ 27576 /en=e07087n

    47i97n 0e95in27h 279i 27l7/ 5e/0uluh 2797h /enuBu B79in7n sehin7

    6e9B72i e2e/7. Glo0ulin : Menin876

    Glo0ulin /e9u5787n s7l7h s76u >978si u67/7 59o6ein 27l7/ 2797h.

    -e9un7 un6u8 si98ul7si ion3 ho9/on 27n 7s7/ le/78. -e0e9757 Benis

    lo0ulin /eni876 he/olo0in3 0e0e9757 l7inn=7 /eni876 H76 0esi30e9>unsi un6u8 /el7e8si3 27n 0e96in278 se077i >786o9 8o7ul7si.

    Pe/e9i8s77n 2797h =7n 2i7nBu987n 5727 GGK 727l7h 87279 se9u/

    89e76inin 27n 0loo2 u9e7 ni69oen !-UN%. I7 727l7h 5e/e9i8s77n =7n

    0i7s7 2il78u87n un6u8 /oni6o9 8el7in7n inB7l. P9o6ein 89e76inin 727l7h

    h7sil 2e9727si no9/7l o6o6 27n u9e7 727l7h h7sil 78hi9 /e670olis/e

    59o6ein. 7sil 8e2u7n=7 /enin876 27l7/ 2797h Bi87 727n=7 57n=78i6 5727

    inB7l.

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    14/21

    '. ASSESSMENT

    P9o0le/ Me2i8 Te975i Assess/en6 Re8o/en27siLeu8osi6

    /enin876

    A/5i4illin i. 1

    97/;h79i

    In>e8si

    -u6uh

    5en=esu7i7n 2osis

    #*" / 5e9 o97l

    se6i75 1# B7/

    !796/7n e6 7l3

    #"1"%.Pe9u6 0es79

    !he9ni7%3

    Pe/e9i8s77n

    5uns 7si6es !?%

    L7si #A i. Asi6es

    O076 6i278 e>e86i>3

    6e927576 6e975i

    =7n le0h e>e86i>

    Menun787n

    579es6esis

    !il6ono%.

    Mu7l R7n6in 1A i.5727 67n7l

    1,;1;1' 27n

    1;1;1'

    Te975i 6i2782i5e9lu87n3 6i278

    727 in2i87si

    Pe/0e9i7nn=7h7n=7 2i0e9i87n

    5727 67n7l

    1);1;1'

    $. PLANa. Tujuan tera+i

    1% Menin87687n 8u7li67s hi2u5 57sien#% Men4e7h 8o/5li87si CRF !T%

    '% Menelu7987n 47i97n 7si6es 2en7n parasitesi (ngga tau namanyaapa)s

    $% Men7n6i87n >unsi 8e9B7 inB7l 2en7n he/o2i7lis7*% Menu97ni 59oesii67s 8e9us787n inB7l

    b. Tera+i !on-,ar"akologi

    1% Mene97587n 7=7 hi2u5 seh76#% Mel78u87n ol7h977 9in7n se4797 9u6in'% Die6 9en27h n769iu/$% Me/5e907n=78 8onsu/si /787n7n =7n /en7n2un 7s7/ >ol76 27n

    0esi =7n 6ini.*% Menhin279i 8onsu/si 7l4ohol 27n 9o8o8+% Menin87687n 8onsu/si 7i9 5u6ih,% Menin87687n 8onsu/si susu 0e987lsiu/ !Di5i9o ,6h e23#"")%.)% Pe/0e9i7n 697ns>usi PRC% e/o2i7lisis

    c. Tera+i ,ar"akologi

    !a"a bat Dosis ,rekuensi n/ikasi

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    15/21

    O# $;5/ -il72i5e9lu87n

    Ses78 n757s357sien 6i278 s7279

    In>us 2e69ose*

    1" TPM in7 KRS Men7/07h ene9i

    A/5i4illin #*" / 5.o # 1 An6i0io6i8 un6u8s7lu97n

    5e9n757s7n

    InBe8si 97n6in 1 A/5ul i #$ B7/ Men767si /u7l879en7 ESOA/5i4illin

    -i4n76 # >l7sh 29i5 Asis2osis/e670oli8

    A/lo2i5in 1" / #$ B7/ i5e96ensi3/enu9un87n TDhin7 1$";"//

    Ce>69i78son 1 9 # #$ B7/ An6i0io6i8 se6el7he/o2i7lisis

    e/o2i7lisis #;/inu Men7n6i >unsiinB7l

    T97ns>. PRC -il72i5e9lu87n

    Un6u8/enhil7n87n7ne/i7

    !Di5i9o ,6h e23 #"")%.

    /. 0onitoring

    N7/7 O076 Moni6o9in T79e6Ke0e9h7sil7n

    Ke0e9h7sil7n ESO

    O# Ses783 RR Ti278 ses783 RR no9/7l

    In>us 2e69ose

    *

    le/7s Ru7/

    8uli63/u7l3

    Ti278 le/7s

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    16/21

    /un67h

    A/5i4illin In>e8si O97lC7n2i2i7sis

    In>e8si3 /onosi6/enu9un3

    li/>osi6 n7i8

    InBe8si 97n6in /u7l S78i6 8e57l738ons6i57si32i79e

    Ti278 /u7l!/u7l 879en7ESO 7/5i4illin%

    -i4n76 Asi2osis/e670oli8

    E2e/73hi5o87le/i73/e670oli87l87losis

    K7279 u9eu/no9/7l

    A/lo2i5in TD3 CAD R7s7 h7us/enin8763>l76ulen3

    TD no9/7l!1$";" //%

    Ce>69i78son i In>e8si 0786e9i S78i6 8e57l730e98e9in7632i79e

    Men4e7hin>e8si 0786e9i

    e/o2i7lisis Funsi inB7l6e97n6i87n

    CAD Funsi inB7l27576

    6e97n6i87nT97ns>. PRC Ane/i7 Ren67n 2en7n

    in>e8si 27n 7278on67/in7si

    0786e9i

    Ti278 7ne/i7

    e. K1

    1% KIE un6u8 6en77 8eseh767n: Se2i77n =7n 5e9lu 2iinBe8si87n 5727 57sien 727l7h A/5i4illin 27n

    R7n6in Se2i77n -i4n76 5e/0e9i7nn=7 2il79u687n 27l7/ L79u67n De69ose

    * *""44 Pe9lu 2il78u87n 5ene4e87n 9u6in U9eu/ 2797h3 7l0u/in3 03

    leu8osi6. A570il7 6e9B72i e>e8 s7/5in3 /787 2il78u87n e7lu7si 5enun77n

    o076

    #% KIE un6u8 8elu797 57sien

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    17/21

    C797 /inu/ o076 27n >9e8uensin=7. Me/5e9h76i87n 27n /enin7687n B72

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    18/21

    Ce>l76oin 19 # 1 h79i An6i0io6i83In>e8si 6u9un

    Di0e9i87nse6el7h Dun6u8/en4e7hin>e8si

    T97n>usiPRC

    Menhil7n87n;/enu9un87neB7l7 7ne/i7

    Un6u8/enu9un87nMC(3 RDW3E9i69osi6

    D. DISKUSI !Pe967n=77n 27n &769i78son 2en7n A/5i4illin

    -77i/7n7 8esesu7i7n 2osisn=7 8e 57sien

    &7 Benis coccus !8e07n=787n s5esies

    streptococcus% 27n enterococcus. An6i0io6i8 =7n u/u/ 2iun787n

    727l7h olon7n 4e>7los5o9in ene97si 8e6i7. Di/7n7 4e>69i78son =7n

    2iun787n /7su8 27l7/ olon7n 27n ene97si 8e6i7 279i 4e>7los5o9in.P727 87sus 57sien 5e/0e9i7n 4e>69i78son 27n 7/5i4illin su27h 6e576

    2i/7n7 2en7n 8o/0in7si 8e2u7 7n6i0io6i8 ini 2ih7975787n 787n

    /enh7sil87n e>e8 6e975i =7n le0ih e>e86i> Bi87 2i07n2in87n 2en7n

    5e/0e9i7n 67n57 8o/0in7si !Moo9e 7n2 Ai6h7l3 #""+%.

    #. Al7s7n 5enun77n olu/e 4on69ol 9ein>usion 27n 077i/7n7 59oses

    5el78s7n77nn=7

    &779/78oloi 07i 57sien =7n /en2e9i67 massive refractory ascites, =7i6u

    8on2isi 7s4i6es 5727 57sien su27h 6i278 27576 2i67n7ni l7i 2en7n

    5enun77n 7en >79/78oloi. P7sien Ds9 2i0e9i87n 6e975i 7s4i6es 2en7n

    /enun787n volume control reinfusion 879en7 6e975i 2en7n

    /enun787n o076 olon7n 2iu9e6i8 un6u8 /e/0u7n 47i97n 7s4i6es

    su27h 6i278 l7i e>e86i> 78i076 inB7l 57sien su27h 6i278 0e9>unsi 2en7n

    07i8 sehin7 57sien 6i278 0is7 /ene8s89esi87n 47i97n 7s4i6es /es8i5un

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    19/21

    su27h 2i0e9i87n 7en 2iu9e6i8. Volume control reinfusion /e9u5787n s7l7h

    s76u 6e975i 5enelu797n 47i97n 7s4i6es =7n 6i278 27576 2i767si 2en7n

    /enun787n he/o2i7lisis. Te975i ini 2il78u87n 0e9s7/77n 2en7n

    he/o2i7lisis 2i/7n7 47i97n 7s4i6es 2i5o/5787n 8elu79 279i 9on7

    5e9i6one7l 57sien /el7lui 2i7lise9 !su et al., #"11%.

    E. KESIMPULAN

    &72i 279i 87sus CRF 2en7n 7s4i6es o076 =7n 2iun787n un6u8

    6e975in=7 =7i6u O8sien 2en7n 2osis $;65/ 0il7 2i5e9lu87n un6u8 ses78

    7s/73 in>use 2e69os7 * 2osisn=7 1" TPM un6u8 /en7/07h ene9i3

    A/5i4illin 2osisn=7 #*" / 5e9 o97l # #$ B7/ un6u8 7n6i0io6i83 inBe8si

    97n6in 1 7/5ul i. 1 #$ B7/ un6u8 /en767si /u7l 879en7 ESO A/5i4illin3

    -i4n76 2osisn=7 # >l7sh 29i5 un6u8 7si2osis /e670oli83 A/lo2i5in 2osisn=7 1"

    / 1 #$ B7/ un6u8 i5e96ensi !/enu9un87n 6e87n7n 2797h 1$";" //%3

    Ce>69i78son 2osisn=7 1 97/ # #$ B7/ un6u8 7n6i0io6i8 se6el7h he/o2i7lisis3

    e/o2i7lisis #;/inu un6u8 /en7n6i87n >unsi inB7l3 697ns>usi PRC

    0il7 2i5e9lu87n un6u8 /enhil7n87n 7ne/i7. Se27n87n o076 =7n 6i278

    2iun787n h7n=7 inBe8si L7si.

    DAFTAR PUSTAKA

    A8h/72i3 #"1$3 Penu8u97n T7n27 (i97l, UGM Journal: Yo=787967.

    796/7n -3 e6 7l.3 #"1"3 D9u The975= in P76ien6s Wi6h Ch9oni4 Ren7l F7ilu9e3

    tsc! "r#tebl $nt3 1", !',%.

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    20/21

    Moo9e3 K.P.3 Ai6h7l3 G.P.3 #""+3 Gui%elines &n '!e Management &f "scites $nCirr!osis3 Unie9si6= Collee Me2i47l S4hool: Lon2on.

    su3 e6 7l.3 #"113 Rein>usion o> As4i6es Du9in e/o2i7l=sis 7s 7 T9e76/en6 o>

    M7ssie Re>9746o9= As4i6es 7n2 A4u6e Ren7l F7ilu9e3 $nt J ep!rol

    Renovasc3 $: #''.

    &NC)3 #"1$3 Ei2en4e-7se2 Gui2line >o9 M7n7e/en6 o> ih -loo2 P9essu9e

    in A2ul6s3"merican Me%ical "ssociation.

    S7n6os73 -u2i.3 #"",3an%uan iagnosa *epera+atan "" --/--03

    P9i/7 Me2i87: &787967.

    LAMPIRAN

  • 7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk

    21/21